We provide quality laboratory services in the following disciplines.
Haematology & Immunohaematology
The Haematology section provides both routine and specialised haematological investigations. We subscribe to College of American Pathologists (CAP) Laboratory Improvement Programs as well as participate in the Ministry of Health National Proficiency Testing Scheme.
We also perform basic coagulation studies and subscribe to CAP Laboratory Improvement Programs to ensure technical competency and consistency in testing.
The Haematology section uses both automation and manual techniques in the analysis of tests. We have defined workflow, which ensures the smooth running of tests and to provide accurate precise reporting of results by the laboratory personnel. Our Consultant Haematologist also provides the expert consultation and review of challenging cases.
The Biochemistry section conducts qualitative and quantitative analysis mainly on blood and urine specimens, in which chemical and biochemical methods are applied in the study of disease.
We provide tests for renal function, liver function, cardiac risk assessment, bone/joint function as well as diabetic screening. With analysis by the robotic automation system, the test results are validated by regular monitoring with the internal and external proficiency testing and quality controls. Test results are accurate and available within the shortened turnaround time, so as to be useful to the clinician in the diagnosis and treatment of disease.
Immunology & Serology
This section offers a comprehensive and high quality range of testing for a variety of illnesses in thyroids, fertility hormones, oncology markers, infectious diseases and autoimmunity. It is well-equipped with the state-of-the-art automated immunology analysers. Stringent internal quality control is carried out in every shift daily and external quality control is performed periodically to ensure the quality results reported.
Majority of tests are performed on serum to determine the presence of antibodies produced by the human body in response to infectious organisms. The presence of IgM antibodies will help the physician to diagnose current infection whereas the presence of IgG antibodies determines immunity developed due to past infection. The panels of testing will provide a clearer picture of patient immune status and thus aid in better patient care management.
Oncology markers can also be used to help in therapy checking and monitoring of the patient.
Therapeutic Drug Monitoring
Body Fluids, Seminal Fluid, Urine & Stool Analysis
The Microbiology section provides a comprehensive range of services covering the isolation, identification and antibiotic sensitivity testing of bacteria, fungi culture and detection of parasites.
In line with the corporate mission of providing high quality healthcare services, the Microbiology section, together with all other sections of Parkway Laboratory Services, subscribes to College of American Pathologists (CAP) Laboratory Improvement Programs. This program serves as a platform to ensure technical competency and consistency in testing in order to provide patients with accurate and clinically relevant test results. The section also participates in the Ministry of Health National Proficiency Testing Scheme for acid-fast bacilli (AFB) and is accredited to provide AFB testing services.
Under the direction of our Consultant Microbiologist, the Microbiology section has been able to achieve a close and informed relationship with doctors in respect of the services provided, particularly the rapid access to results, opinion and advice.
Clinical Molecular (PCR Testing) & Specialised Testing
The Clinical Molecular Section offers tests using PCR, Elisa and Chemiluminescent methods.
For PCR, we provide detection on Hepatitis B and C, Chlamydia trachomatis and M. tuberculosis. Various types of antibodies detection are done by Elisa method such as Herpes simplex type I and II, Chlamydia, Epstein Barr Virus, H. pylori and Varicella-zoster virus.
In addition, tests on autoimmune disease, e.g. anti-ds DNA and anti-Cardiolipin antibodies are performed in this section. A wide range of hormones such as IgF-1, GH, ACTH, Dheas, PTH and Insulin as well as infectious diseases, Toxoplasmosis and Rubella are tested using chemiluminescent technology.
The Pap smear is a screening test for cancer of the uterine cervix. It is an excellent method to examine cells collected from the cervix to identify cells which show precancerous or cancerous changes. This allows detection of early lesions, thus more effective treatment can be administered.
Two types of specimens are available, that is, conventional PAP smear and liquid-based preparation (ThinPrep). By using ThinPrep method, we can see an improvement in the detection of epithelial cell abnormalities, due to the improvement of the cellular adequacy. It provides clear, easy to read slides as compared to conventional smears, which may have overlapping thick and thin areas or air drying artefacts.
Qualified cytotechnologists will do evaluation of all Pap smears. Pathologists will be responsible for the final interpretation of all abnormal cases.
We are using the 2001 Bethesda system that provides uniformity in laboratory reporting of Pap smears.
The use of cytology as a screening test for cancer in sites other than uterine cervix can aid in diagnosis of early clinical stages of disease based either on symptoms or clinical suspicion. Early detection of cancer means more chances of successful treatment. It is a non-invasive way of assessing cells for the presence of pre-cancerous of cancerous changes and can also provide information about non-cancerous conditions (for example, infections).
There are three processing methods, which are direct smears, cytocentrifugation-based preparations (cytospin) and cell block. Both of the latter methods allow ancillary tests such as special stains, immunocytochemical stains and molecular testing.
On site cellular assessment of FNA/EUS-FNA has significantly reduced the inadequacy rate of cytology as the cytotechnologist can prepare and examine smears to assess if there are sufficient cells for cytological evaluation.
Triple Testing for Down’s Syndrome